A Randomized Controlled Study Comparing the Efficacy and Safety of R2-CHOP versus R-CHOP as First-Line Treatment for Elderly Patients with HIV-Associated Diffuse Large B-Cell Lymphoma (ChiCTR) - Oct 16, 2026 - P2 | N=120 | Not yet recruiting | Sponsor: Southern Medical University Southern Hospital; Southern Medical University Southern Hospital
New P2 trial • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Human Immunodeficiency Virus • Infectious Disease • Lymphoma • Non-Hodgkin's Lymphoma • Oncology
|